Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$57.89 - $64.73 $12,851 - $14,370
-222 Reduced 0.39%
57,016 $3.31 Million
Q2 2023

Jul 18, 2023

BUY
$63.71 - $70.74 $21,406 - $23,768
336 Added 0.59%
57,238 $3.66 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $38,308 - $43,450
-583 Reduced 1.01%
56,902 $3.94 Million
Q4 2022

Jan 10, 2023

SELL
$68.48 - $81.09 $40,334 - $47,762
-589 Reduced 1.01%
57,485 $0
Q3 2022

Oct 27, 2022

BUY
$0.13 - $76.84 $62 - $36,729
478 Added 0.83%
58,074 $4.13 Million
Q2 2022

Jul 29, 2022

BUY
$72.62 - $79.98 $61,363 - $67,583
845 Added 1.49%
57,596 $4.44 Million
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $3.49 Million - $4.18 Million
56,751 New
56,751 $4.15 Million
Q4 2021

Jan 26, 2022

SELL
$53.63 - $62.52 $1.92 Million - $2.24 Million
-35,802 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$59.17 - $69.31 $1.76 Million - $2.06 Million
-29,740 Reduced 45.38%
35,802 $2.12 Million
Q2 2021

Jul 12, 2021

BUY
$61.91 - $67.42 $169,014 - $184,056
2,730 Added 4.35%
65,542 $4.38 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $3.73 Million - $4.19 Million
62,812 New
62,812 $3.97 Million
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $2.54 Million - $3.3 Million
-52,169 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $111,373 - $125,620
2,018 Added 4.02%
52,169 $3.24 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $2.53 Million - $3.16 Million
50,151 New
50,151 $2.78 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Avitas Wealth Management LLC Portfolio

Follow Avitas Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.